Table 3 The relative risk of conversion to COPD among different groups after 3 years
From: Metabolic syndrome, small airway dysfunction and the mediating role of inflammation
Model 1 | Model 2 | ||||
|---|---|---|---|---|---|
NO (IR %) | RR (95% CI) | P-value | RR (95% CI) | P-value | |
conversion to COPD | |||||
Normal | 7(0.94)) | 1.0 (reference) | 1.0 (reference) | ||
isolated SAD | 52(8.86) | 7.12(2.65–19.12) | < 0.001 | 8.80(3.33–23.26) | < 0.001 |
isolated MetS | 3(1.68) | 0.929(0.19–4.65) | 0.928 | 1.03(0.21–5.12) | 0.973 |
MetS + SAD | 14(9.09) | 11.09(4.88–25.23) | < 0.001 | 10.36(4.58–23.46) | < 0.001 |
